Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study | Louise Cosand | DMCN

In this podcast, Louise Cosand discusses her paper 'Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study'.   The paper is available here: https://doi.org/10.1111/dmcn.16482   Follow DMCN on Podbean for more:  https://dmcn.podbean.com/ ___ Watch DMCN Podcasts on YouTube: https://bit.ly/2ONCYiC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families.   DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749 ___ Find us on Twitter! @mackeithpress - https://twitter.com/mackeithpress